Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Javelin Medical's primary focus?
- Javelin Medical is developing the Vine device, a permanent filter implanted in the carotid arteries, to prevent stroke in individuals with atrial fibrillation by intercepting blood clots.
- When was Javelin Medical founded?
- Javelin Medical was founded in May 2012.
- What is the current status of Javelin Medical's Vine device?
- The Vine device is currently available for individuals with atrial fibrillation through participation in the CAPTURE II study in several European countries.
- Where is Javelin Medical headquartered?
- Javelin Medical is headquartered in Yokne'am Illit, Israel.
- What is Javelin Medical's current funding stage?
- According to startupim data, Javelin Medical is currently in the Pre-Funding stage.
- How many employees does Javelin Medical have?
- Javelin Medical has 16 employees.
- Who are the founders of Javelin Medical?
- The founders of Javelin Medical are Ofer Yodfat and Guy Shinar.
- What is a notable news event for Javelin Medical?
- On May 11, 2019, MedPage Today reported on Javelin Medical's novel carotid filter aiming for stroke prevention in Afib.